Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
Table 4
Characteristics of ICU patients treated with a triple therapy (lopinavir/ritonavir and hydroxychloroquine) compared to a control group.